syndrome	score	normalized_score
ACROCAPITOFEMORAL DYSPLASIA; ACFD	1.00393701	100.0
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	1.0	99.60784292632064
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	1.0	99.60784292632064
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	1.0	99.60784292632064
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.50873239	50.6737359946517
HYPOCHONDROPLASIA	0.50393701	50.19607853683967
BRACHYDACTYLY, TYPE A6	0.50121359	49.924804545257274
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.50121359	49.924804545257274
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.50121359	49.924804545257274
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.50121359	49.924804545257274
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.5	49.80392146316032
BRACHYDACTYLY, TYPE D	0.5	49.80392146316032
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.5	49.80392146316032
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	49.80392146316032
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.5	49.80392146316032
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.5	49.80392146316032
#606835 DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB	0.5	49.80392146316032
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	49.80392146316032
BRACHYDACTYLY, TYPE E	0.33727001	33.59473817983859
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.33454659	33.32346418825619
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.333333	33.20258110615924
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.333333	33.20258110615924
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.333333	33.20258110615924
BRACHYDACTYLY, TYPE B1	0.333333	33.20258110615924
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.25896553	25.794997835571376
KABUKI SYNDROME 1	0.25121359	25.022843813677113
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.25	24.90196073158016
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.25	24.90196073158016
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.25	24.90196073158016
#615346 PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2	0.25	24.90196073158016
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.25	24.90196073158016
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.25	24.90196073158016
ROIFMAN SYNDROME; RFMN	0.23331074000000002	23.239579542943638
#200700 CHONDRODYSPLASIA, GREBE TYPE;;ACHONDROGENESIS, BRAZILIAN;;GREBE CHONDRODYSPLASIA;;GREBE DYSPLASIA;;ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;;ACHONDROGENESIS, TYPE II, FORMERLY	0.2	19.92156858526413
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.2	19.92156858526413
268650 RUDIGER SYNDROME	0.2	19.92156858526413
HOLT-ORAM SYNDROME	0.2	19.92156858526413
CHROMOSOME 17q12 DELETION SYNDROME	0.15158939	15.09949214841676
PELGER-HUET ANOMALY; PHA	0.14285699999999998	14.229677616925388
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.14285699999999998	14.229677616925388
HYDROLETHALUS SYNDROME 1	0.14285699999999998	14.229677616925388
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.14285699999999998	14.229677616925388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.14285699999999998	14.229677616925388
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.14285699999999998	14.229677616925388
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.12280491000000002	12.232332185860944
SILVER-RUSSELL SYNDROME; SRS	0.10503694	10.462503020981366
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.10341479	10.300924158578436
NOONAN SYNDROME 2; NS2	0.10121359000000002	10.081667374729019
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.08454689000000001	8.421533339028912
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.08454689000000001	8.421533339028912
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.08454689000000001	8.421533339028912
NOONAN SYNDROME 10; NS10	0.08454689000000001	8.421533339028912
AORTIC VALVE DISEASE 1; AOVD1	0.08333330000000001	8.300650256931958
STORM SYNDROME	0.08333330000000001	8.300650256931958
PSEUDOXANTHOMA ELASTICUM; PXE	0.08333330000000001	8.300650256931958
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.08333330000000001	8.300650256931958
GAUCHER DISEASE, TYPE IIIC	0.08333330000000001	8.300650256931958
VELOCARDIOFACIAL SYNDROME	0.08087039	8.055325104510292
CLEIDORHIZOMELIC SYNDROME	0.06657544	6.631435970270684
BRACHYDACTYLY, TYPE A1, D	0.06657544	6.631435970270684
BRACHYDACTYLY, TYPE A2; BDA2	0.06657544	6.631435970270684
SYNPOLYDACTYLY 1	0.06657544	6.631435970270684
BRACHYDACTYLY, TYPE A3	0.06657544	6.631435970270684
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	0.0639741	6.3723221041527305
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.0639741	6.3723221041527305
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.06276051	6.251439022055777
CLEIDOCRANIAL DYSPLASIA; CCD	0.06276051	6.251439022055777
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.06003709	5.980165030473375
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.06003709	5.980165030473375
245800 LAURENCE-MOON SYNDROME	0.06003709	5.980165030473375
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.06003709	5.980165030473375
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.06003709	5.980165030473375
ALSTROM SYNDROME; ALMS	0.06003709	5.980165030473375
WIDOW&#39;S PEAK SYNDROME	0.06003709	5.980165030473375
MUCOLIPIDOSIS III GAMMA	0.06003709	5.980165030473375
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	5.863883830719619
Jawad syndrome	0.0588235	5.859281948376423
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.0588235	5.859281948376423
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0588235	5.859281948376423
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0588235	5.859281948376423
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0588235	5.859281948376423
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0588235	5.859281948376423
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0588235	5.859281948376423
EPISODIC ATAXIA, TYPE 1; EA1	0.0588235	5.859281948376423
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.0588235	5.859281948376423
BRACHYDACTYLY, TYPE A4	0.0588235	5.859281948376423
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0588235	5.859281948376423
DERMOCHONDROCORNEAL DYSTROPHY	0.0588235	5.859281948376423
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0588235	5.859281948376423
Fabry disease	0.0588235	5.859281948376423
HALLERMANN-STREIFF SYNDROME; HSS	0.0588235	5.859281948376423
POTOCKI-LUPSKI SYNDROME	0.04719389	4.700881582202055
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.04239851	4.223224124390034
WATSON SYNDROME	0.03967509	3.9519501328076347
CHROMOSOME 10Q26 DELETION SYNDROME	0.03871359	3.8561771918339773
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	3.831067050710682
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	3.831067050710682
MUSCULAR HYPERTONIA, LETHAL	0.0384615	3.831067050710682
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.0384615	3.831067050710682
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	3.831067050710682
PREPAPILLARY VASCULAR LOOPS	0.0384615	3.831067050710682
BETHLEM MYOPATHY 1	0.0384615	3.831067050710682
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	3.831067050710682
ATROPHODERMA VERMICULATA; AVA	0.0384615	3.831067050710682
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	3.831067050710682
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0384615	3.831067050710682
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	3.831067050710682
COWDEN SYNDROME 5; CWS5	0.0384615	3.831067050710682
THUMB DEFORMITY	0.0384615	3.831067050710682
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	3.831067050710682
COWDEN SYNDROME 6; CWS6	0.0384615	3.831067050710682
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	3.831067050710682
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	3.831067050710682
ARTERIES, ANOMALIES OF	0.0384615	3.831067050710682
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	3.831067050710682
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	3.831067050710682
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.03674819	3.6604079373465868
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0330776	3.2947883851796638
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.03252225	3.239471169610532
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.03252225	3.239471169610532
%300712 CRANIOFACIOSKELETAL SYNDROME	0.02956924	2.9453282133706775
MUCOLIPIDOSIS III ALPHA/BETA	0.02956569	2.944974605528289
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.029373729999999997	2.9258538840001522
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029373729999999997	2.9258538840001522
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.028585239999999998	2.8473140959311776
BLOOM SYNDROME	0.028585239999999998	2.8473140959311776
PETERS-PLUS SYNDROME; PTRPLS	0.02835565	2.8244451312737238
ELSAHY-WATERS SYNDROME; ESWS	0.02812251	2.8012225587738815
WILLIAMS-BEUREN SYNDROME; WBS	0.02783343	2.7724279235407407
HUNTER-MACDONALD SYNDROME	0.02783343	2.7724279235407407
COFFIN-LOWRY SYNDROME; CLS	0.02760029	2.7492053510408985
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.02563223	2.5531711396913237
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.02563223	2.5531711396913237
CORNEODERMATOOSSEOUS SYNDROME	0.0255588	2.545856935785244
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.02539909	2.5299485671914814
BARDET-BIEDL SYNDROME 1; BBS1	0.02477031	2.4673171477162694
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.02477031	2.4673171477162694
BRANCHIOOCULOFACIAL SYNDROME	0.02441864	2.43228805759437
WARBURG MICRO SYNDROME 3; WARBM3	0.02441864	2.43228805759437
KNIEST-LIKE DYSPLASIA, LETHAL	0.02434521	2.4249738536882908
ATELOSTEOGENESIS, TYPE I; AO1	0.02434521	2.4249738536882908
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.024018499999999998	2.392430975325832
WEILL-MARCHESANI SYNDROME 1; WMS1	0.024018499999999998	2.392430975325832
WEILL-MARCHESANI SYNDROME 2; WMS2	0.02280491	2.2715478932288793
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.02204689	2.1960431561338694
DIGEORGE SYNDROME; DGS	0.02204689	2.1960431561338694
SHPRINTZEN OMPHALOCELE SYNDROME	0.02204689	2.1960431561338694
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.02204689	2.1960431561338694
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.02204689	2.1960431561338694
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.02204689	2.1960431561338694
MICROPHTHALMIA, SYNDROMIC 3	0.02204689	2.1960431561338694
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.02204689	2.1960431561338694
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.02204689	2.1960431561338694
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.02204689	2.1960431561338694
PRADER-WILLI SYNDROME; PWS	0.02204689	2.1960431561338694
NEUROFIBROMATOSIS, TYPE I	0.02204689	2.1960431561338694
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.02204689	2.1960431561338694
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.021817299999999998	2.173174191476415
COSTELLO SYNDROME; CSTLO	0.02162179	2.1536998621058903
TYSHCHENKO SYNDROME	0.02162179	2.1536998621058903
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.02162179	2.1536998621058903
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.02162179	2.1536998621058903
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.02162179	2.1536998621058903
Diamond-Blackfan anemia 1	0.02162179	2.1536998621058903
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.02162179	2.1536998621058903
TEMPLE SYNDROME	0.02162179	2.1536998621058903
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.02162179	2.1536998621058903
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.02162179	2.1536998621058903
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.0208333	2.0751600740369156
TUBEROUS SCLEROSIS 2; TSC2	0.0208333	2.0751600740369156
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0208333	2.0751600740369156
ALAGILLE SYNDROME 1; ALGS1	0.0208333	2.0751600740369156
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	2.0751600740369156
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.0208333	2.0751600740369156
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0208333	2.0751600740369156
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.0208333	2.0751600740369156
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.0208333	2.0751600740369156
LEGIUS SYNDROME	0.0208333	2.0751600740369156
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0208333	2.0751600740369156
FEINGOLD SYNDROME 1; FGLDS1	0.0208333	2.0751600740369156
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0208333	2.0751600740369156
TUBEROUS SCLEROSIS	0.0208333	2.0751600740369156
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0208333	2.0751600740369156
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0208333	2.0751600740369156
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.0208333	2.0751600740369156
LISSENCEPHALY, X-LINKED, 2	0.0208333	2.0751600740369156
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0208333	2.0751600740369156
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0208333	2.0751600740369156
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0208333	2.0751600740369156
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0208333	2.0751600740369156
MUSICAL PERFECT PITCH	0.0208333	2.0751600740369156
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.0208333	2.0751600740369156
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.0208333	2.0751600740369156
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.02060371	2.052291109379462
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.02060371	2.052291109379462
#614976 CARPENTER SYNDROME 2; CRPT2	0.02060371	2.052291109379462
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.02060371	2.052291109379462
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	2.032816780008937
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	2.032816780008937
GAUCHER DISEASE, PERINATAL LETHAL	0.020408199999999998	2.032816780008937
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	2.032816780008937
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	2.032816780008937
KAGAMI-OGATA SYNDROME	0.020408199999999998	2.032816780008937
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.020408199999999998	2.032816780008937
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	2.032816780008937
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020408199999999998	2.032816780008937
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.020408199999999998	2.032816780008937
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.020408199999999998	2.032816780008937
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	2.032816780008937
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	2.032816780008937
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	2.032816780008937
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	2.032816780008937
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	2.032816780008937
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	2.032816780008937
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	2.032816780008937
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	2.032816780008937
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.020408199999999998	2.032816780008937
NEMALINE MYOPATHY 10	0.020408199999999998	2.032816780008937
YUNIS-VARON SYNDROME	0.020408199999999998	2.032816780008937
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	2.032816780008937
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.020408199999999998	2.032816780008937
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.020408199999999998	2.032816780008937
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	2.032816780008937
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.020408199999999998	2.032816780008937
INFANTILE SIALIC ACID STORAGE DISEASE	0.020408199999999998	2.032816780008937
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.020408199999999998	2.032816780008937
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	2.032816780008937
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	2.032816780008937
ASPARTYLGLUCOSAMINURIA; AGU	0.02008149	2.000273901646479
HURLER-SCHEIE SYNDROME	0.02008149	2.000273901646479
LOEYS-DIETZ SYNDROME 5	0.02008149	2.000273901646479
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.02008149	2.000273901646479
HURLER SYNDROME	0.02008149	2.000273901646479
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	1.9530906625307103
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	1.9530906625307103
#215300 CHONDROSARCOMA	0.0196078	1.9530906625307103
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	1.9530906625307103
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	1.9530906625307103
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0196078	1.9530906625307103
BAND HETEROTOPIA; BH	0.0196078	1.9530906625307103
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.9530906625307103
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.9530906625307103
PUBIC BONE DYSPLASIA	0.0196078	1.9530906625307103
THROMBOCYTOPENIA 3	0.0196078	1.9530906625307103
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.9530906625307103
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.9530906625307103
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	1.9530906625307103
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	1.9530906625307103
VESICOURETERAL REFLUX 1	0.0196078	1.9530906625307103
MEGAEPIPHYSEAL DWARFISM	0.0196078	1.9530906625307103
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0196078	1.9530906625307103
KNUCKLE PADS	0.0196078	1.9530906625307103
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.9530906625307103
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.9530906625307103
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	1.9530906625307103
TRACHEOBRONCHOMEGALY	0.0196078	1.9530906625307103
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	1.9530906625307103
TOE, MISSHAPEN	0.0196078	1.9530906625307103
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	1.9530906625307103
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	1.9530906625307103
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	1.9530906625307103
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0196078	1.9530906625307103
LETTERER-SIWE DISEASE	0.0196078	1.9530906625307103
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.9530906625307103
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.9530906625307103
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	1.9530906625307103
MONOPHALANGY OF GREAT TOE	0.0196078	1.9530906625307103
SPINAL ARACHNOIDITIS	0.0196078	1.9530906625307103
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	1.9530906625307103
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.9530906625307103
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.9530906625307103
CARPAL DISPLACEMENT	0.0196078	1.9530906625307103
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.9530906625307103
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.9530906625307103
NEPHROSIALIDOSIS	0.0196078	1.9530906625307103
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.9530906625307103
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.9530906625307103
HHHH SYNDROME	0.0196078	1.9530906625307103
RAYNAUD DISEASE	0.0196078	1.9530906625307103
VAN DEN BOSCH SYNDROME	0.0196078	1.9530906625307103
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.9530906625307103
THUMBS, CONGENITAL CLASPED	0.0196078	1.9530906625307103
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.9530906625307103
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	1.9530906625307103
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01920775	1.9132425449680353
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.01920775	1.9132425449680353
LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	0.0188679	1.8793908195495252
MITRAL VALVE PROLAPSE, MYXOMATOUS 2	0.0188679	1.8793908195495252
HEART BLOCK, CONGENITAL	0.0188679	1.8793908195495252
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.0188679	1.8793908195495252
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0188679	1.8793908195495252
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.0188679	1.8793908195495252
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26	0.0188679	1.8793908195495252
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.0188679	1.8793908195495252
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.0188679	1.8793908195495252
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27	0.0188679	1.8793908195495252
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0188679	1.8793908195495252
CARDIOMYOPATHY, DILATED, 1NN	0.0188679	1.8793908195495252
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.0188679	1.8793908195495252
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0188679	1.8793908195495252
MARFANOID HYPERMOBILITY SYNDROME	0.0188679	1.8793908195495252
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0188679	1.8793908195495252
MITRAL VALVE PROLAPSE, MYXOMATOUS 3	0.0188679	1.8793908195495252
HAMAMY SYNDROME; HMMS	0.0188679	1.8793908195495252
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.0188679	1.8793908195495252
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.0188679	1.8793908195495252
LEFT VENTRICULAR NONCOMPACTION 8; LVNC8	0.0188679	1.8793908195495252
CARDIOMYOPATHY, DILATED, 1KK; CMD1KK	0.0188679	1.8793908195495252
POLYCYSTIC KIDNEYS	0.0188679	1.8793908195495252
LOEYS-DIETZ SYNDROME 3; LDS3	0.0188679	1.8793908195495252
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.0188679	1.8793908195495252
MEESTER-LOEYS SYNDROME; MRLS	0.0188679	1.8793908195495252
MARFAN SYNDROME; MFS	0.0188679	1.8793908195495252
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.0188679	1.8793908195495252
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.0188679	1.8793908195495252
ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA	0.0188679	1.8793908195495252
#614434 CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	0.0188679	1.8793908195495252
OPTIC ATROPHY 8	0.0188679	1.8793908195495252
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0188679	1.8793908195495252
CARDIOMYOPATHY, DILATED, 1Y; CMD1Y	0.0188679	1.8793908195495252
Contractural arachnodactyly, congenital	0.0188679	1.8793908195495252
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0188679	1.8793908195495252
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.0188679	1.8793908195495252
#615184 CARDIOMYOPATHY, DILATED, 1II; CMD1II	0.0188679	1.8793908195495252
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.0188679	1.8793908195495252
BOHRING-OPITZ SYNDROME	0.01788029	1.7810171177970617
Pierpont syndrome	0.01788029	1.7810171177970617
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.01788029	1.7810171177970617
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.01788029	1.7810171177970617
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01788029	1.7810171177970617
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.01788029	1.7810171177970617
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.01788029	1.7810171177970617
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.01788029	1.7810171177970617
TEEBI-SHALTOUT SYNDROME; TBSH	0.01788029	1.7810171177970617
NOONAN SYNDROME 4; NS4	0.01788029	1.7810171177970617
KOOLEN-DE VRIES SYNDROME; KDVS	0.01788029	1.7810171177970617
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0166667	1.6601340357001084
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0166667	1.6601340357001084
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.0166667	1.6601340357001084
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0166667	1.6601340357001084
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.0166667	1.6601340357001084
GOLDBERG-SHPRINTZEN SYNDROME	0.0166667	1.6601340357001084
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.0166667	1.6601340357001084
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.0166667	1.6601340357001084
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0166667	1.6601340357001084
SCARF SYNDROME	0.0166667	1.6601340357001084
CHROMOSOME 16Q22 DELETION SYNDROME	0.0166667	1.6601340357001084
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0166667	1.6601340357001084
BARTSOCAS-PAPAS SYNDROME; BPS	0.0166667	1.6601340357001084
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0166667	1.6601340357001084
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0166667	1.6601340357001084
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0166667	1.6601340357001084
MACDERMOT-WINTER SYNDROME	0.0166667	1.6601340357001084
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.0166667	1.6601340357001084
CHROMOSOME 9P DELETION SYNDROME	0.0166667	1.6601340357001084
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0166667	1.6601340357001084
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0166667	1.6601340357001084
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.0166667	1.6601340357001084
AU-KLINE SYNDROME; AUKS	0.0166667	1.6601340357001084
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0166667	1.6601340357001084
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.0166667	1.6601340357001084
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.0166667	1.6601340357001084
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0166667	1.6601340357001084
227320 FACIOTHORACOGENITAL SYNDROME	0.0166667	1.6601340357001084
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0166667	1.6601340357001084
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0166667	1.6601340357001084
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0166667	1.6601340357001084
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.01648433	1.6419685533856352
RENPENNING SYNDROME 1; RENS1	0.01648433	1.6419685533856352
MOLAR I REINCLUSION	0.01527074	1.5210854712886817
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01527074	1.5210854712886817
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.01527074	1.5210854712886817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.01527074	1.5210854712886817
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.01290254	1.285194177670569
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.01290254	1.285194177670569
CORNELIA DE LANGE SYNDROME 3	0.01290254	1.285194177670569
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.01290254	1.285194177670569
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.01290254	1.285194177670569
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.01290254	1.285194177670569
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.01290254	1.285194177670569
CRANIOFRONTONASAL SYNDROME; CFNS	0.01290254	1.285194177670569
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01290254	1.285194177670569
AYME-GRIPP SYNDROME; AYGRP	0.0126694	1.2619716051707268
SCHAAF-YANG SYNDROME; SHFYNG	0.0126694	1.2619716051707268
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.0126694	1.2619716051707268
WHITE-SUTTON SYNDROME; WHSUS	0.0126694	1.2619716051707268
SMITH-MAGENIS SYNDROME; SMS	0.0126694	1.2619716051707268
RAINE SYNDROME	0.0126694	1.2619716051707268
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0126694	1.2619716051707268
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0126694	1.2619716051707268
Myhre syndrome	0.0126694	1.2619716051707268
CHROMOSOME 1P36 DELETION SYNDROME	0.01168895	1.1643110955736158
ACROCALLOSAL SYNDROME; ACLS	0.01168895	1.1643110955736158
WEYERS ACROFACIAL DYSOSTOSIS	0.01168895	1.1643110955736158
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.01168895	1.1643110955736158
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.01168895	1.1643110955736158
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.01168895	1.1643110955736158
HAND-FOOT-GENITAL SYNDROME; HFG	0.01168895	1.1643110955736158
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.01168895	1.1643110955736158
JACOBSEN SYNDROME	0.01168895	1.1643110955736158
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.01168895	1.1643110955736158
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.01168895	1.1643110955736158
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.01168895	1.1643110955736158
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.01145581	1.1410885230737733
15q26 overgrowth syndrome	0.01145581	1.1410885230737733
BASAL CELL NEVUS SYNDROME	0.01145581	1.1410885230737733
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.01145581	1.1410885230737733
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.01145581	1.1410885230737733
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.01145581	1.1410885230737733
KLEEFSTRA SYNDROME	0.01145581	1.1410885230737733
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.01145581	1.1410885230737733
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.01145581	1.1410885230737733
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.00896553	0.8930371039912155
JOHANSON-BLIZZARD SYNDROME; JBS	0.00896553	0.8930371039912155
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00896553	0.8930371039912155
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00896553	0.8930371039912155
POPOV-CHANG SYNDROME; POPCHAS	0.00896553	0.8930371039912155
FLOATING-HARBOR SYNDROME	0.00896553	0.8930371039912155
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00896553	0.8930371039912155
SECKEL SYNDROME 2; SCKL2	0.00896553	0.8930371039912155
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00896553	0.8930371039912155
OHDO SYNDROME	0.00896553	0.8930371039912155
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00896553	0.8930371039912155
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00896553	0.8930371039912155
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00896553	0.8930371039912155
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00896553	0.8930371039912155
PELVIS-SHOULDER DYSPLASIA	0.00896553	0.8930371039912155
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00896553	0.8930371039912155
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00896553	0.8930371039912155
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00896553	0.8930371039912155
CORNELIA DE LANGE SYNDROME 1	0.00896553	0.8930371039912155
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00896553	0.8930371039912155
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00896553	0.8930371039912155
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00896553	0.8930371039912155
NAIL-PATELLA SYNDROME	0.00896553	0.8930371039912155
LARSEN-LIKE SYNDROME	0.00896553	0.8930371039912155
SECKEL SYNDROME 5; SCKL5	0.00896553	0.8930371039912155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00896553	0.8930371039912155
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00896553	0.8930371039912155
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00873239	0.8698145314913731
FONTAINE PROGEROID SYNDROME; FPS	0.00873239	0.8698145314913731
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00873239	0.8698145314913731
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00873239	0.8698145314913731
MCDONOUGH SYNDROME	0.00873239	0.8698145314913731
XQ25 DUPLICATION SYNDROME	0.00873239	0.8698145314913731
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00873239	0.8698145314913731
Rothmund-Thomson syndrome	0.00873239	0.8698145314913731
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00873239	0.8698145314913731
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00873239	0.8698145314913731
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00873239	0.8698145314913731
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00873239	0.8698145314913731
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00873239	0.8698145314913731
CHROMOSOME 18Q DELETION SYNDROME	0.00873239	0.8698145314913731
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00873239	0.8698145314913731
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00873239	0.8698145314913731
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00873239	0.8698145314913731
#611554 LEOPARD SYNDROME 2	0.00873239	0.8698145314913731
LUSCAN-LUMISH SYNDROME; LLS	0.00873239	0.8698145314913731
Trichothiodystrophy 5, nonphotosensitive	0.00873239	0.8698145314913731
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00873239	0.8698145314913731
NOONAN SYNDROME 5; NS5	0.00873239	0.8698145314913731
MEIER-GORLIN SYNDROME 1; MGORS1	0.00775194	0.772154021894262
MICROCEPHALY-CARDIOMYOPATHY	0.00775194	0.772154021894262
TALONAVICULAR COALITION	0.00775194	0.772154021894262
CHAR SYNDROME	0.00775194	0.772154021894262
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.00775194	0.772154021894262
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00775194	0.772154021894262
Glycosylphosphatidylinositol biosynthesis defect 18	0.00775194	0.772154021894262
3MC SYNDROME 1	0.00775194	0.772154021894262
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00775194	0.772154021894262
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00775194	0.772154021894262
FIBROCHONDROGENESIS 1; FBCG1	0.00775194	0.772154021894262
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00775194	0.772154021894262
CATEL-MANZKE SYNDROME; CATMANS	0.00775194	0.772154021894262
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.00775194	0.772154021894262
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.00775194	0.772154021894262
PHELAN-MCDERMID SYNDROME; PHMDS	0.00775194	0.772154021894262
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00775194	0.772154021894262
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00775194	0.772154021894262
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.00775194	0.772154021894262
CHROMOSOME 16p13.2 DELETION SYNDROME	0.00775194	0.772154021894262
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00775194	0.772154021894262
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00775194	0.772154021894262
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00775194	0.772154021894262
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00775194	0.772154021894262
TETRALOGY OF FALLOT	0.00775194	0.772154021894262
WT LIMB-BLOOD SYNDROME	0.00775194	0.772154021894262
BOWEN-CONRADI SYNDROME	0.00775194	0.772154021894262
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00775194	0.772154021894262
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00775194	0.772154021894262
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00775194	0.772154021894262
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00775194	0.772154021894262
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00775194	0.772154021894262
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.00775194	0.772154021894262
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00775194	0.772154021894262
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00775194	0.772154021894262
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.00775194	0.772154021894262
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00775194	0.772154021894262
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00775194	0.772154021894262
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00775194	0.772154021894262
SECKEL SYNDROME 1; SCKL1	0.00775194	0.772154021894262
ZUNICH NEUROECTODERMAL SYNDROME	0.00775194	0.772154021894262
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00775194	0.772154021894262
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00775194	0.772154021894262
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.00775194	0.772154021894262
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.00775194	0.772154021894262
CHROMOSOME 16p13.3 DELETION SYNDROME	0.00775194	0.772154021894262
DUBOWITZ SYNDROME	0.00775194	0.772154021894262
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00775194	0.772154021894262
PALLISTER-KILLIAN SYNDROME	0.00775194	0.772154021894262
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00775194	0.772154021894262
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00775194	0.772154021894262
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.0075188	0.7489314493944197
HAREL-YOON SYNDROME; HAYOS	0.0075188	0.7489314493944197
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0075188	0.7489314493944197
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0075188	0.7489314493944197
SOTOS SYNDROME 2	0.0075188	0.7489314493944197
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0075188	0.7489314493944197
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.0075188	0.7489314493944197
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.0075188	0.7489314493944197
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.0075188	0.7489314493944197
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0075188	0.7489314493944197
ZIMMERMANN-LABAND SYNDROME 1	0.0075188	0.7489314493944197
GERODERMA OSTEODYSPLASTICUM; GO	0.0075188	0.7489314493944197
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0075188	0.7489314493944197
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0075188	0.7489314493944197
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0075188	0.7489314493944197
SCHEIE SYNDROME	0.0075188	0.7489314493944197
VAN BUCHEM DISEASE, TYPE 2	0.0075188	0.7489314493944197
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0075188	0.7489314493944197
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.0075188	0.7489314493944197
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0075188	0.7489314493944197
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.0075188	0.7489314493944197
BARBER-SAY SYNDROME; BBRSAY	0.0075188	0.7489314493944197
BARTH SYNDROME; BTHS	0.0075188	0.7489314493944197
COCKAYNE SYNDROME A; CSA	0.0075188	0.7489314493944197
SCLEROSTEOSIS 1; SOST1	0.0075188	0.7489314493944197
FRAGILE X MENTAL RETARDATION SYNDROME	0.0075188	0.7489314493944197
ANGELMAN SYNDROME	0.0075188	0.7489314493944197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0075188	0.7489314493944197
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0075188	0.7489314493944197
MORQUIO SYNDROME A	0.0075188	0.7489314493944197
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0075188	0.7489314493944197
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.0075188	0.7489314493944197
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.0075188	0.7489314493944197
CAMURATI-ENGELMANN DISEASE	0.0075188	0.7489314493944197
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0075188	0.7489314493944197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.0075188	0.7489314493944197
Sotos syndrome	0.0075188	0.7489314493944197
TURNPENNY-FRY SYNDROME; TPFS	0.0075188	0.7489314493944197
Lipodystrophy, congenital generalized, type 2	0.0075188	0.7489314493944197
MENTAL RETARDATION, X-LINKED 107; MRX107	0.0075188	0.7489314493944197
MAXILLOFACIAL DYSOSTOSIS	0.0075188	0.7489314493944197
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.0075188	0.7489314493944197
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0075188	0.7489314493944197
WEAVER SYNDROME	0.0075188	0.7489314493944197
%608572 BURN-MCKEOWN SYNDROME	0.0075188	0.7489314493944197
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0075188	0.7489314493944197
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0075188	0.7489314493944197
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0075188	0.7489314493944197
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.0075188	0.7489314493944197
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.0075188	0.7489314493944197
PROGNATHISM, MANDIBULAR	0.0075188	0.7489314493944197
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.0075188	0.7489314493944197
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0075188	0.7489314493944197
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0075188	0.7489314493944197
MARFANOID HABITUS WITH SITUS INVERSUS	0.0075188	0.7489314493944197
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0075188	0.7489314493944197
AREDYLD	0.0075188	0.7489314493944197
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.0075188	0.7489314493944197
Lipodystrophy, congenital generalized, type 1	0.0075188	0.7489314493944197
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0075188	0.7489314493944197
TENORIO SYNDROME; TNORS	0.0075188	0.7489314493944197
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.0075188	0.7489314493944197
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.0075188	0.7489314493944197
PYLE DISEASE; PYL	0.0075188	0.7489314493944197
PETTIGREW SYNDROME	0.0075188	0.7489314493944197
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0075188	0.7489314493944197
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0075188	0.7489314493944197
CROUZON SYNDROME	0.0075188	0.7489314493944197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.0075188	0.7489314493944197
SCLEROSTEOSIS 2; SOST2	0.0075188	0.7489314493944197
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.0075188	0.7489314493944197
SOTOS SYNDROME 3	0.0075188	0.7489314493944197
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0075188	0.7489314493944197
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0075188	0.7489314493944197
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.0075188	0.7489314493944197
RAYNAUD-CLAES SYNDROME; MRXSRC	0.0075188	0.7489314493944197
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0075188	0.7489314493944197
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.0051506	0.513040155776307
SATOYOSHI SYNDROME	0.0051506	0.513040155776307
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0051506	0.513040155776307
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0051506	0.513040155776307
COFFIN-SIRIS SYNDROME 2; CSS2	0.0051506	0.513040155776307
OROFACIODIGITAL SYNDROME VI	0.0051506	0.513040155776307
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0051506	0.513040155776307
CHITAYAT SYNDROME	0.0051506	0.513040155776307
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0051506	0.513040155776307
SPONDYLOPERIPHERAL DYSPLASIA	0.0051506	0.513040155776307
ANAUXETIC DYSPLASIA 2; ANXD2	0.0051506	0.513040155776307
#300867 KABUKI SYNDROME 2; KABUK2	0.0051506	0.513040155776307
WITTEVEEN-KOLK SYNDROME	0.0051506	0.513040155776307
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0051506	0.513040155776307
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0051506	0.513040155776307
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.0051506	0.513040155776307
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0051506	0.513040155776307
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0051506	0.513040155776307
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.0051506	0.513040155776307
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0051506	0.513040155776307
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.0051506	0.513040155776307
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.0051506	0.513040155776307
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.0051506	0.513040155776307
BRACHYDACTYLY, TYPE E2; BDE2	0.0051506	0.513040155776307
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0051506	0.513040155776307
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0051506	0.513040155776307
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.0051506	0.513040155776307
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.0051506	0.513040155776307
CRANIOECTODERMAL DYSPLASIA 3	0.0051506	0.513040155776307
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.0051506	0.513040155776307
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.0051506	0.513040155776307
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.0051506	0.513040155776307
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0051506	0.513040155776307
COFFIN-SIRIS SYNDROME 7; CSS7	0.0051506	0.513040155776307
GRACILE BONE DYSPLASIA; GCLEB	0.0051506	0.513040155776307
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0051506	0.513040155776307
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0051506	0.513040155776307
RHYNS SYNDROME; RHYNS	0.0051506	0.513040155776307
EIKEN SYNDROME	0.0051506	0.513040155776307
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.0051506	0.513040155776307
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0051506	0.513040155776307
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0051506	0.513040155776307
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.0051506	0.513040155776307
PYCNODYSOSTOSIS	0.0051506	0.513040155776307
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0051506	0.513040155776307
Smith-Magenis Syndrome	0.0051506	0.513040155776307
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0051506	0.513040155776307
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.0051506	0.513040155776307
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0051506	0.513040155776307
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.0051506	0.513040155776307
FOCAL DERMAL HYPOPLASIA; FDH	0.0051506	0.513040155776307
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0051506	0.513040155776307
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.0051506	0.513040155776307
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0051506	0.513040155776307
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.0051506	0.513040155776307
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.0051506	0.513040155776307
FEINGOLD SYNDROME 2; FGLDS2	0.0051506	0.513040155776307
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.0051506	0.513040155776307
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0051506	0.513040155776307
WEILL-MARCHESANI SYNDROME 4; WMS4	0.0051506	0.513040155776307
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0051506	0.513040155776307
Retinitis pigmentosa with or without skeletal anomalies	0.0051506	0.513040155776307
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0051506	0.513040155776307
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0051506	0.513040155776307
608028 THAI SYMPHALANGISM SYNDROME	0.0051506	0.513040155776307
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.0051506	0.513040155776307
Aarskog-Scott syndrome	0.0051506	0.513040155776307
MACS SYNDROME	0.0051506	0.513040155776307
OROFACIODIGITAL SYNDROME IV; OFD4	0.0051506	0.513040155776307
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.0051506	0.513040155776307
COFFIN-SIRIS SYNDROME 6; CSS6	0.0051506	0.513040155776307
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.0051506	0.513040155776307
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.0051506	0.513040155776307
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0051506	0.513040155776307
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.0051506	0.513040155776307
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0051506	0.513040155776307
CHOPS SYNDROME; CHOPS	0.0051506	0.513040155776307
OROFACIODIGITAL SYNDROME I; OFD1	0.0051506	0.513040155776307
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0051506	0.513040155776307
WEILL-MARCHESANI SYNDROME 3	0.0051506	0.513040155776307
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.0051506	0.513040155776307
MULTIPLE SYNOSTOSES SYNDROME 2	0.00393701	0.3921570736793537
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.00393701	0.3921570736793537
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00393701	0.3921570736793537
KEIPERT SYNDROME; KPTS	0.00393701	0.3921570736793537
Muenke syndrome	0.00393701	0.3921570736793537
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00393701	0.3921570736793537
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00393701	0.3921570736793537
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00393701	0.3921570736793537
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00393701	0.3921570736793537
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00393701	0.3921570736793537
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00393701	0.3921570736793537
DESBUQUOIS DYSPLASIA 1	0.00393701	0.3921570736793537
GENITOPATELLAR SYNDROME; GTPTS	0.00393701	0.3921570736793537
POTOCKI-SHAFFER SYNDROME	0.00393701	0.3921570736793537
SYMPHALANGISM, DISTAL	0.00393701	0.3921570736793537
BARDET-BIEDL SYNDROME 3; BBS3	0.00393701	0.3921570736793537
CRANIOECTODERMAL DYSPLASIA 1	0.00393701	0.3921570736793537
ADAMS-OLIVER SYNDROME 5; AOS5	0.00393701	0.3921570736793537
GRANGE SYNDROME; GRNG	0.00393701	0.3921570736793537
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00393701	0.3921570736793537
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00393701	0.3921570736793537
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00393701	0.3921570736793537
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00393701	0.3921570736793537
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00393701	0.3921570736793537
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00393701	0.3921570736793537
#100800 ACHONDROPLASIA; ACH	0.00393701	0.3921570736793537
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00393701	0.3921570736793537
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00393701	0.3921570736793537
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00393701	0.3921570736793537
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00393701	0.3921570736793537
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.00393701	0.3921570736793537
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00393701	0.3921570736793537
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00393701	0.3921570736793537
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00393701	0.3921570736793537
ADAMS-OLIVER SYNDROME 1; AOS1	0.00393701	0.3921570736793537
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00393701	0.3921570736793537
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00393701	0.3921570736793537
TEMTAMY SYNDROME; TEMTYS	0.00393701	0.3921570736793537
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00393701	0.3921570736793537
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.00393701	0.3921570736793537
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00393701	0.3921570736793537
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00393701	0.3921570736793537
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00393701	0.3921570736793537
METATROPIC DYSPLASIA	0.00393701	0.3921570736793537
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00393701	0.3921570736793537
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00393701	0.3921570736793537
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00393701	0.3921570736793537
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00393701	0.3921570736793537
MAL DE MELEDA	0.00393701	0.3921570736793537
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00393701	0.3921570736793537
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00393701	0.3921570736793537
ODONTOCHONDRODYSPLASIA; ODCD	0.00393701	0.3921570736793537
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00393701	0.3921570736793537
Temtamy preaxial brachydactyly syndrome	0.00393701	0.3921570736793537
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00393701	0.3921570736793537
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00393701	0.3921570736793537
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00393701	0.3921570736793537
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.00393701	0.3921570736793537
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00393701	0.3921570736793537
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00393701	0.3921570736793537
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00393701	0.3921570736793537
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00393701	0.3921570736793537
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00393701	0.3921570736793537
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.00393701	0.3921570736793537
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00393701	0.3921570736793537
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00393701	0.3921570736793537
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00393701	0.3921570736793537
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00393701	0.3921570736793537
BARDET-BIEDL SYNDROME 5; BBS5	0.00393701	0.3921570736793537
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00393701	0.3921570736793537
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00393701	0.3921570736793537
SYNDACTYLY, TYPE V	0.00393701	0.3921570736793537
BARDET-BIEDL SYNDROME 17; BBS17	0.00393701	0.3921570736793537
CAMPTOBRACHYDACTYLY	0.00393701	0.3921570736793537
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.00393701	0.3921570736793537
SCHNECKENBECKEN DYSPLASIA	0.00393701	0.3921570736793537
CRANIOSYNOSTOSIS 2	0.00393701	0.3921570736793537
ROBERTS SYNDROME; RBS	0.00393701	0.3921570736793537
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00393701	0.3921570736793537
BARDET-BIEDL SYNDROME 18; BBS18	0.00393701	0.3921570736793537
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00393701	0.3921570736793537
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00393701	0.3921570736793537
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00393701	0.3921570736793537
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00393701	0.3921570736793537
BARDET-BIEDL SYNDROME 4; BBS4	0.00393701	0.3921570736793537
ADAMS-OLIVER SYNDROME 6; AOS6	0.00393701	0.3921570736793537
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.00393701	0.3921570736793537
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00393701	0.3921570736793537
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00393701	0.3921570736793537
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00393701	0.3921570736793537
AL-RAQAD SYNDROME; ARS	0.00393701	0.3921570736793537
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00393701	0.3921570736793537
BRACHYDACTYLY, LONG-THUMB TYPE	0.00393701	0.3921570736793537
THANATOPHORIC DYSPLASIA, TYPE II	0.00393701	0.3921570736793537
#612576 CHROMOSOME 17P13.3, TELOMERIC, DUPLICATION SYNDROME;;SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	0.00393701	0.3921570736793537
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00393701	0.3921570736793537
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00393701	0.3921570736793537
MOEBIUS SYNDROME; MBS	0.00393701	0.3921570736793537
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00393701	0.3921570736793537
BARATELA-SCOTT SYNDROME	0.00393701	0.3921570736793537
PSEUDOACHONDROPLASIA	0.00393701	0.3921570736793537
2q37 monosomy	0.00393701	0.3921570736793537
FRONTONASAL DYSPLASIA 1; FND1	0.00393701	0.3921570736793537
KEARNS-SAYRE SYNDROME; KSS	0.00121359	0.12088308209695348
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00121359	0.12088308209695348
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00121359	0.12088308209695348
HARTNUP DISORDER	0.00121359	0.12088308209695348
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00121359	0.12088308209695348
Orofaciodigital syndrome XVII	0.00121359	0.12088308209695348
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00121359	0.12088308209695348
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00121359	0.12088308209695348
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00121359	0.12088308209695348
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00121359	0.12088308209695348
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00121359	0.12088308209695348
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00121359	0.12088308209695348
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00121359	0.12088308209695348
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00121359	0.12088308209695348
260150 PALANT CLEFT PALATE SYNDROME	0.00121359	0.12088308209695348
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00121359	0.12088308209695348
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00121359	0.12088308209695348
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.00121359	0.12088308209695348
OCULOPALATOCEREBRAL SYNDROME	0.00121359	0.12088308209695348
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED 99	0.00121359	0.12088308209695348
EXOSTOSES, MULTIPLE, TYPE I	0.00121359	0.12088308209695348
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00121359	0.12088308209695348
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.00121359	0.12088308209695348
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00121359	0.12088308209695348
RAPADILINO SYNDROME	0.00121359	0.12088308209695348
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00121359	0.12088308209695348
CRANIOECTODERMAL DYSPLASIA 4	0.00121359	0.12088308209695348
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00121359	0.12088308209695348
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.00121359	0.12088308209695348
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00121359	0.12088308209695348
FORSYTHE-WAKELING SYNDROME; FWS	0.00121359	0.12088308209695348
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.00121359	0.12088308209695348
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00121359	0.12088308209695348
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00121359	0.12088308209695348
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00121359	0.12088308209695348
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00121359	0.12088308209695348
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00121359	0.12088308209695348
LEGG-CALVE-PERTHES DISEASE	0.00121359	0.12088308209695348
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00121359	0.12088308209695348
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00121359	0.12088308209695348
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00121359	0.12088308209695348
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00121359	0.12088308209695348
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00121359	0.12088308209695348
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00121359	0.12088308209695348
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00121359	0.12088308209695348
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00121359	0.12088308209695348
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00121359	0.12088308209695348
HYPERTELORISM, TEEBI TYPE; TBHS	0.00121359	0.12088308209695348
PERRAULT SYNDROME 3	0.00121359	0.12088308209695348
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00121359	0.12088308209695348
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00121359	0.12088308209695348
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00121359	0.12088308209695348
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00121359	0.12088308209695348
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00121359	0.12088308209695348
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00121359	0.12088308209695348
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00121359	0.12088308209695348
IMMUNODEFICIENCY 58; IMD58	0.00121359	0.12088308209695348
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00121359	0.12088308209695348
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00121359	0.12088308209695348
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.00121359	0.12088308209695348
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.00121359	0.12088308209695348
MIRAGE SYNDROME; MIRAGE	0.00121359	0.12088308209695348
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00121359	0.12088308209695348
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00121359	0.12088308209695348
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00121359	0.12088308209695348
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00121359	0.12088308209695348
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00121359	0.12088308209695348
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00121359	0.12088308209695348
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00121359	0.12088308209695348
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.00121359	0.12088308209695348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00121359	0.12088308209695348
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00121359	0.12088308209695348
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00121359	0.12088308209695348
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00121359	0.12088308209695348
STEEL SYNDROME; STLS	0.00121359	0.12088308209695348
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00121359	0.12088308209695348
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00121359	0.12088308209695348
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00121359	0.12088308209695348
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.00121359	0.12088308209695348
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00121359	0.12088308209695348
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00121359	0.12088308209695348
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.00121359	0.12088308209695348
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00121359	0.12088308209695348
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00121359	0.12088308209695348
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00121359	0.12088308209695348
SECKEL SYNDROME 4	0.00121359	0.12088308209695348
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00121359	0.12088308209695348
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00121359	0.12088308209695348
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00121359	0.12088308209695348
MENKES DISEASE	0.00121359	0.12088308209695348
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00121359	0.12088308209695348
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00121359	0.12088308209695348
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00121359	0.12088308209695348
#612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12	0.00121359	0.12088308209695348
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00121359	0.12088308209695348
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00121359	0.12088308209695348
OSTEOGENESIS IMPERFECTA, TYPE V	0.00121359	0.12088308209695348
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00121359	0.12088308209695348
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00121359	0.12088308209695348
MARINESCO-SJOGREN SYNDROME; MSS	0.00121359	0.12088308209695348
COFFIN-SIRIS SYNDROME 4; CSS4	0.00121359	0.12088308209695348
PROPIONIC ACIDEMIA	0.00121359	0.12088308209695348
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00121359	0.12088308209695348
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00121359	0.12088308209695348
WARBURG MICRO SYNDROME 1	0.00121359	0.12088308209695348
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00121359	0.12088308209695348
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.00121359	0.12088308209695348
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.00121359	0.12088308209695348
Helsmoortel-van der Aa syndrome	0.00121359	0.12088308209695348
OPTIC ATROPHY 11; OPA11	0.00121359	0.12088308209695348
STIFF SKIN SYNDROME	0.00121359	0.12088308209695348
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00121359	0.12088308209695348
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00121359	0.12088308209695348
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00121359	0.12088308209695348
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00121359	0.12088308209695348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00121359	0.12088308209695348
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00121359	0.12088308209695348
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.00121359	0.12088308209695348
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00121359	0.12088308209695348
BRUCK SYNDROME 2	0.00121359	0.12088308209695348
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00121359	0.12088308209695348
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00121359	0.12088308209695348
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00121359	0.12088308209695348
BIEMOND SYNDROME II	0.00121359	0.12088308209695348
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00121359	0.12088308209695348
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00121359	0.12088308209695348
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00121359	0.12088308209695348
RADIAL-RENAL SYNDROME	0.00121359	0.12088308209695348
JOUBERT SYNDROME 26	0.00121359	0.12088308209695348
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00121359	0.12088308209695348
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00121359	0.12088308209695348
AL KAISSI SYNDROME; ALKAS	0.00121359	0.12088308209695348
SPONDYLOOCULAR SYNDROME; SOS	0.00121359	0.12088308209695348
PALLISTER-HALL SYNDROME	0.00121359	0.12088308209695348
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.00121359	0.12088308209695348
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00121359	0.12088308209695348
PFEIFFER-PALM-TELLER SYNDROME	0.00121359	0.12088308209695348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00121359	0.12088308209695348
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00121359	0.12088308209695348
HYPOPHOSPHATEMIC BONE DISEASE	0.00121359	0.12088308209695348
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00121359	0.12088308209695348
WERNER SYNDROME; WRN	0.00121359	0.12088308209695348
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00121359	0.12088308209695348
DYSTONIA 28, CHILDHOOD-ONSET	0.00121359	0.12088308209695348
MASA SYNDROME	0.00121359	0.12088308209695348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00121359	0.12088308209695348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00121359	0.12088308209695348
NIEMANN-PICK DISEASE, TYPE B	0.00121359	0.12088308209695348
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00121359	0.12088308209695348
GLASS SYNDROME	0.00121359	0.12088308209695348
SAY SYNDROME	0.00121359	0.12088308209695348
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.00121359	0.12088308209695348
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00121359	0.12088308209695348
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00121359	0.12088308209695348
PRECOCIOUS PUBERTY, CENTRAL	0.00121359	0.12088308209695348
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00121359	0.12088308209695348
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00121359	0.12088308209695348
ACROCRANIOFACIAL DYSOSTOSIS	0.00121359	0.12088308209695348
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00121359	0.12088308209695348
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00121359	0.12088308209695348
OSTEOGENESIS IMPERFECTA, TYPE X	0.00121359	0.12088308209695348
C SYNDROME	0.00121359	0.12088308209695348
ALAZAMI-YUAN SYNDROME	0.00121359	0.12088308209695348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.00121359	0.12088308209695348
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00121359	0.12088308209695348
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00121359	0.12088308209695348
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00121359	0.12088308209695348
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00121359	0.12088308209695348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00121359	0.12088308209695348
#300582 SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.00121359	0.12088308209695348
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00121359	0.12088308209695348
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00121359	0.12088308209695348
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00121359	0.12088308209695348
NIJMEGEN BREAKAGE SYNDROME	0.00121359	0.12088308209695348
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00121359	0.12088308209695348
ZTTK SYNDROME; ZTTKS	0.00121359	0.12088308209695348
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00121359	0.12088308209695348
SACCHAROPINURIA	0.00121359	0.12088308209695348
DIAMOND-BLACKFAN ANEMIA 4	0.00121359	0.12088308209695348
LYMPHEDEMA, HEREDITARY, III	0.00121359	0.12088308209695348
Potocki-Lupski syndrome (17p11.2 duplication syndrome)	0.00121359	0.12088308209695348
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00121359	0.12088308209695348
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00121359	0.12088308209695348
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00121359	0.12088308209695348
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00121359	0.12088308209695348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00121359	0.12088308209695348
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.00121359	0.12088308209695348
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00121359	0.12088308209695348
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00121359	0.12088308209695348
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00121359	0.12088308209695348
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00121359	0.12088308209695348
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.00121359	0.12088308209695348
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00121359	0.12088308209695348
CASPASE 8 DEFICIENCY	0.00121359	0.12088308209695348
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.00121359	0.12088308209695348
MARTSOLF SYNDROME	0.00121359	0.12088308209695348
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00121359	0.12088308209695348
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00121359	0.12088308209695348
EHLERS-DANLOS SYNDROME, TYPE I	0.00121359	0.12088308209695348
COHEN SYNDROME	0.00121359	0.12088308209695348
LATERAL MENINGOCELE SYNDROME	0.00121359	0.12088308209695348
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00121359	0.12088308209695348
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.00121359	0.12088308209695348
HOLOPROSENCEPHALY 1; HPE1	0.00121359	0.12088308209695348
NOONAN SYNDROME 6; NS6	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED 92	0.00121359	0.12088308209695348
STORMORKEN SYNDROME; STRMK	0.00121359	0.12088308209695348
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00121359	0.12088308209695348
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00121359	0.12088308209695348
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.00121359	0.12088308209695348
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.00121359	0.12088308209695348
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00121359	0.12088308209695348
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00121359	0.12088308209695348
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00121359	0.12088308209695348
MOWAT-WILSON SYNDROME; MOWS	0.00121359	0.12088308209695348
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00121359	0.12088308209695348
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00121359	0.12088308209695348
#613986 PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	0.00121359	0.12088308209695348
#278250 WRINKLY SKIN SYNDROME; WSS	0.00121359	0.12088308209695348
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.00121359	0.12088308209695348
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00121359	0.12088308209695348
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00121359	0.12088308209695348
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00121359	0.12088308209695348
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00121359	0.12088308209695348
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00121359	0.12088308209695348
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00121359	0.12088308209695348
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00121359	0.12088308209695348
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00121359	0.12088308209695348
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00121359	0.12088308209695348
22q11.2 distal deletion syndrome	0.00121359	0.12088308209695348
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.00121359	0.12088308209695348
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.00121359	0.12088308209695348
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00121359	0.12088308209695348
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00121359	0.12088308209695348
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.00121359	0.12088308209695348
MICROHYDRANENCEPHALY; MHAC	0.00121359	0.12088308209695348
SIFRIM-HITZ-WEISS SYNDROME	0.00121359	0.12088308209695348
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00121359	0.12088308209695348
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00121359	0.12088308209695348
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00121359	0.12088308209695348
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00121359	0.12088308209695348
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.00121359	0.12088308209695348
3MC SYNDROME 3	0.00121359	0.12088308209695348
OROFACIODIGITAL SYNDROME IX; OFD9	0.00121359	0.12088308209695348
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00121359	0.12088308209695348
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00121359	0.12088308209695348
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.00121359	0.12088308209695348
NOONAN SYNDROME 11; NS11	0.00121359	0.12088308209695348
#612649 CILIARY DYSKINESIA, PRIMARY, 11; CILD11	0.00121359	0.12088308209695348
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00121359	0.12088308209695348
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00121359	0.12088308209695348
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.00121359	0.12088308209695348
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.00121359	0.12088308209695348
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.00121359	0.12088308209695348
RODRIGUES BLINDNESS	0.00121359	0.12088308209695348
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.00121359	0.12088308209695348
LISSENCEPHALY 4	0.00121359	0.12088308209695348
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.00121359	0.12088308209695348
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00121359	0.12088308209695348
#150250 LARSEN SYNDROME; LRS	0.00121359	0.12088308209695348
AURICULOOSTEODYSPLASIA	0.00121359	0.12088308209695348
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00121359	0.12088308209695348
#614728 SECKEL SYNDROME 6; SCKL6	0.00121359	0.12088308209695348
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00121359	0.12088308209695348
INCONTINENTIA PIGMENTI; IP	0.00121359	0.12088308209695348
DIAMOND-BLACKFAN ANEMIA 5	0.00121359	0.12088308209695348
LESCH-NYHAN SYNDROME; LNS	0.00121359	0.12088308209695348
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00121359	0.12088308209695348
AROMATASE EXCESS SYNDROME	0.00121359	0.12088308209695348
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00121359	0.12088308209695348
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00121359	0.12088308209695348
NASODIGITOACOUSTIC SYNDROME	0.00121359	0.12088308209695348
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00121359	0.12088308209695348
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00121359	0.12088308209695348
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00121359	0.12088308209695348
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00121359	0.12088308209695348
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00121359	0.12088308209695348
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00121359	0.12088308209695348
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00121359	0.12088308209695348
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00121359	0.12088308209695348
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00121359	0.12088308209695348
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00121359	0.12088308209695348
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00121359	0.12088308209695348
#300555 DENT DISEASE 2	0.00121359	0.12088308209695348
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00121359	0.12088308209695348
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00121359	0.12088308209695348
SAUL-WILSON SYNDROME; SWILS	0.00121359	0.12088308209695348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00121359	0.12088308209695348
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00121359	0.12088308209695348
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00121359	0.12088308209695348
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00121359	0.12088308209695348
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00121359	0.12088308209695348
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00121359	0.12088308209695348
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00121359	0.12088308209695348
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.00121359	0.12088308209695348
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00121359	0.12088308209695348
SONODA SYNDROME	0.00121359	0.12088308209695348
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00121359	0.12088308209695348
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00121359	0.12088308209695348
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00121359	0.12088308209695348
#154780 MARSHALL SYNDROME; MRSHS	0.00121359	0.12088308209695348
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.00121359	0.12088308209695348
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00121359	0.12088308209695348
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00121359	0.12088308209695348
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00121359	0.12088308209695348
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.00121359	0.12088308209695348
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.00121359	0.12088308209695348
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.00121359	0.12088308209695348
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00121359	0.12088308209695348
NAVAJO NEUROHEPATOPATHY	0.00121359	0.12088308209695348
SECKEL SYNDROME 9; SCKL9	0.00121359	0.12088308209695348
DIAMOND-BLACKFAN ANEMIA 10	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00121359	0.12088308209695348
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00121359	0.12088308209695348
KENNERKNECHT SYNDROME	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00121359	0.12088308209695348
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00121359	0.12088308209695348
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00121359	0.12088308209695348
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00121359	0.12088308209695348
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00121359	0.12088308209695348
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00121359	0.12088308209695348
KBG SYNDROME	0.00121359	0.12088308209695348
SEPTOOPTIC DYSPLASIA	0.00121359	0.12088308209695348
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.00121359	0.12088308209695348
ATKIN-FLAITZ SYNDROME	0.00121359	0.12088308209695348
Williams-Beuren Syndrome (WBS)	0.00121359	0.12088308209695348
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00121359	0.12088308209695348
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00121359	0.12088308209695348
SPINAL DYSPLASIA, ANHALT TYPE	0.00121359	0.12088308209695348
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.00121359	0.12088308209695348
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00121359	0.12088308209695348
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00121359	0.12088308209695348
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00121359	0.12088308209695348
NOONAN SYNDROME 9; NS9	0.00121359	0.12088308209695348
#276880 UROCANASE DEFICIENCY	0.00121359	0.12088308209695348
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00121359	0.12088308209695348
STICKLER SYNDROME, TYPE V; STL5	0.00121359	0.12088308209695348
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00121359	0.12088308209695348
NIEMANN-PICK DISEASE, TYPE A	0.00121359	0.12088308209695348
COFFIN-SIRIS SYNDROME 1; CSS1	0.00121359	0.12088308209695348
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00121359	0.12088308209695348
IMMUNODEFICIENCY 55; IMD55	0.00121359	0.12088308209695348
OVARIAN DYSGENESIS 5; ODG5	0.00121359	0.12088308209695348
NEURAMINIDASE DEFICIENCY	0.00121359	0.12088308209695348
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00121359	0.12088308209695348
CHROMOSOME 1p35 DELETION SYNDROME	0.00121359	0.12088308209695348
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00121359	0.12088308209695348
STUVE-WIEDEMANN SYNDROME	0.00121359	0.12088308209695348
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00121359	0.12088308209695348
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00121359	0.12088308209695348
LOWE OCULOCEREBRORENAL SYNDROME	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00121359	0.12088308209695348
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00121359	0.12088308209695348
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00121359	0.12088308209695348
IMMUNODEFICIENCY 36; IMD36	0.00121359	0.12088308209695348
EXOSTOSES, MULTIPLE, TYPE II	0.00121359	0.12088308209695348
RAMON SYNDROME	0.00121359	0.12088308209695348
CHROMOSOME 18P DELETION SYNDROME	0.00121359	0.12088308209695348
Mental retardation, autosomal dominant 21	0.00121359	0.12088308209695348
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00121359	0.12088308209695348
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00121359	0.12088308209695348
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00121359	0.12088308209695348
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00121359	0.12088308209695348
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00121359	0.12088308209695348
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00121359	0.12088308209695348
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00121359	0.12088308209695348
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00121359	0.12088308209695348
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00121359	0.12088308209695348
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00121359	0.12088308209695348
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00121359	0.12088308209695348
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00121359	0.12088308209695348
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00121359	0.12088308209695348
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00121359	0.12088308209695348
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00121359	0.12088308209695348
THORACOPELVIC DYSOSTOSIS	0.00121359	0.12088308209695348
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00121359	0.12088308209695348
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00121359	0.12088308209695348
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00121359	0.12088308209695348
HYPOPHOSPHATASIA, CHILDHOOD	0.00121359	0.12088308209695348
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.00121359	0.12088308209695348
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00121359	0.12088308209695348
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00121359	0.12088308209695348
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00121359	0.12088308209695348
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00121359	0.12088308209695348
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00121359	0.12088308209695348
DENT DISEASE 1	0.00121359	0.12088308209695348
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00121359	0.12088308209695348
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00121359	0.12088308209695348
CHROMOSOME 2q37 DELETION SYNDROME	0.00121359	0.12088308209695348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00121359	0.12088308209695348
SJOGREN-LARSSON SYNDROME; SLS	0.00121359	0.12088308209695348
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00121359	0.12088308209695348
CHARGE-LIKE SYNDROME, X-LINKED	0.00121359	0.12088308209695348
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00121359	0.12088308209695348
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00121359	0.12088308209695348
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00121359	0.12088308209695348
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED 84	0.00121359	0.12088308209695348
HADZISELIMOVIC SYNDROME	0.00121359	0.12088308209695348
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00121359	0.12088308209695348
COFFIN-SIRIS SYNDROME 5	0.00121359	0.12088308209695348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00121359	0.12088308209695348
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00121359	0.12088308209695348
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00121359	0.12088308209695348
WIEACKER-WOLFF SYNDROME	0.00121359	0.12088308209695348
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00121359	0.12088308209695348
HAIRY ELBOWS	0.00121359	0.12088308209695348
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00121359	0.12088308209695348
COFFIN-SIRIS SYNDROME 3; CSS3	0.00121359	0.12088308209695348
SPASTIC PARAPARESIS AND DEAFNESS	0.00121359	0.12088308209695348
NOONAN SYNDROME 3; NS3	0.00121359	0.12088308209695348
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00121359	0.12088308209695348
PELIZAEUS-MERZBACHER DISEASE	0.00121359	0.12088308209695348
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00121359	0.12088308209695348
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00121359	0.12088308209695348
GLYCOGEN STORAGE DISEASE IA	0.00121359	0.12088308209695348
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00121359	0.12088308209695348
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00121359	0.12088308209695348
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00121359	0.12088308209695348
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00121359	0.12088308209695348
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00121359	0.12088308209695348
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00121359	0.12088308209695348
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00121359	0.12088308209695348
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00121359	0.12088308209695348
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00121359	0.12088308209695348
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00121359	0.12088308209695348
CROME SYNDROME	0.00121359	0.12088308209695348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00121359	0.12088308209695348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00121359	0.12088308209695348
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00121359	0.12088308209695348
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00121359	0.12088308209695348
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00121359	0.12088308209695348
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00121359	0.12088308209695348
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00121359	0.12088308209695348
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00121359	0.12088308209695348
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00121359	0.12088308209695348
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00121359	0.12088308209695348
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00121359	0.12088308209695348
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00121359	0.12088308209695348
NOONAN SYNDROME 7; NS7	0.00121359	0.12088308209695348
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00121359	0.12088308209695348
SCHIZOPHRENIA 1; SCZD1	0.00121359	0.12088308209695348
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00121359	0.12088308209695348
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00121359	0.12088308209695348
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.00121359	0.12088308209695348
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00121359	0.12088308209695348
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00121359	0.12088308209695348
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00121359	0.12088308209695348
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00121359	0.12088308209695348
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.00121359	0.12088308209695348
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.00121359	0.12088308209695348
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00121359	0.12088308209695348
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.00121359	0.12088308209695348
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00121359	0.12088308209695348
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.00121359	0.12088308209695348
OGDEN SYNDROME; OGDNS	0.00121359	0.12088308209695348
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00121359	0.12088308209695348
2q33.1 deletion syndrome	0.00121359	0.12088308209695348
DIAMOND-BLACKFAN ANEMIA 8	0.00121359	0.12088308209695348
#613707 LEOPARD SYNDROME 3; LPRD3	0.00121359	0.12088308209695348
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00121359	0.12088308209695348
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00121359	0.12088308209695348
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00121359	0.12088308209695348
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00121359	0.12088308209695348
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00121359	0.12088308209695348
PRIMROSE SYNDROME; PRIMS	0.00121359	0.12088308209695348
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00121359	0.12088308209695348
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00121359	0.12088308209695348
CEREBELLOFACIODENTAL SYNDROME	0.00121359	0.12088308209695348
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00121359	0.12088308209695348
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00121359	0.12088308209695348
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00121359	0.12088308209695348
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00121359	0.12088308209695348
TRICHOHEPATOENTERIC SYNDROME 1	0.00121359	0.12088308209695348
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00121359	0.12088308209695348
FRIAS SYNDROME	0.00121359	0.12088308209695348
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00121359	0.12088308209695348
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00121359	0.12088308209695348
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00121359	0.12088308209695348
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00121359	0.12088308209695348
NOONAN SYNDROME 8; NS8	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED 45	0.00121359	0.12088308209695348
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00121359	0.12088308209695348
THUMB DEFORMITY AND ALOPECIA	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00121359	0.12088308209695348
MEIER-GORLIN SYNDROME 7	0.00121359	0.12088308209695348
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00121359	0.12088308209695348
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00121359	0.12088308209695348
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00121359	0.12088308209695348
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00121359	0.12088308209695348
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00121359	0.12088308209695348
RUVALCABA SYNDROME	0.00121359	0.12088308209695348
#259450 BRUCK SYNDROME 1; BRKS1	0.00121359	0.12088308209695348
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00121359	0.12088308209695348
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00121359	0.12088308209695348
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.00121359	0.12088308209695348
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00121359	0.12088308209695348
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.00121359	0.12088308209695348
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00121359	0.12088308209695348
FOUNTAIN SYNDROME	0.00121359	0.12088308209695348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00121359	0.12088308209695348
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00121359	0.12088308209695348
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00121359	0.12088308209695348
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00121359	0.12088308209695348
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00121359	0.12088308209695348
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00121359	0.12088308209695348
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00121359	0.12088308209695348
COXOAURICULAR SYNDROME	0.00121359	0.12088308209695348
GLYCOGEN STORAGE DISEASE IB	0.00121359	0.12088308209695348
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00121359	0.12088308209695348
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.00121359	0.12088308209695348
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00121359	0.12088308209695348
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00121359	0.12088308209695348
MEVALONIC ACIDURIA; MEVA	0.00121359	0.12088308209695348
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00121359	0.12088308209695348
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00121359	0.12088308209695348
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00121359	0.12088308209695348
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00121359	0.12088308209695348
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00121359	0.12088308209695348
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00121359	0.12088308209695348
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00121359	0.12088308209695348
600736 VELOFACIOSKELETAL SYNDROME	0.00121359	0.12088308209695348
CHROMOSOME 15q25 DELETION SYNDROME	0.00121359	0.12088308209695348
GURRIERI SYNDROME	0.00121359	0.12088308209695348
THREE M SYNDROME 2; 3M2	0.00121359	0.12088308209695348
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00121359	0.12088308209695348
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00121359	0.12088308209695348
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00121359	0.12088308209695348
GLYCEROL KINASE DEFICIENCY; GKD	0.00121359	0.12088308209695348
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00121359	0.12088308209695348
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00121359	0.12088308209695348
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00121359	0.12088308209695348
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00121359	0.12088308209695348
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00121359	0.12088308209695348
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00121359	0.12088308209695348
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00121359	0.12088308209695348
MEND SYNDROME; MEND	0.00121359	0.12088308209695348
RETT SYNDROME; RTT	0.00121359	0.12088308209695348
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00121359	0.12088308209695348
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.00121359	0.12088308209695348
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00121359	0.12088308209695348
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00121359	0.12088308209695348
CODAS SYNDROME	0.00121359	0.12088308209695348
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00121359	0.12088308209695348
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.00121359	0.12088308209695348
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00121359	0.12088308209695348
Cat-Eye Syndrome (Type I)	0.00121359	0.12088308209695348
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00121359	0.12088308209695348
RUIJS-AALFS SYNDROME; RJALS	0.00121359	0.12088308209695348
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00121359	0.12088308209695348
FANCONI ANEMIA	0.00121359	0.12088308209695348
PYGMY	0.00121359	0.12088308209695348
OVARIAN DYSGENESIS 4; ODG4	0.00121359	0.12088308209695348
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00121359	0.12088308209695348
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00121359	0.12088308209695348
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00121359	0.12088308209695348
GLYCOGEN STORAGE DISEASE IXB	0.00121359	0.12088308209695348
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.00121359	0.12088308209695348
CULLER-JONES SYNDROME; CJS	0.00121359	0.12088308209695348
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00121359	0.12088308209695348
MENTAL RETARDATION, X-LINKED 2	0.00121359	0.12088308209695348
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00121359	0.12088308209695348
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00121359	0.12088308209695348
15q24 recurrent microdeletion syndrome	0.00121359	0.12088308209695348
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00121359	0.12088308209695348
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00121359	0.12088308209695348
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00121359	0.12088308209695348
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.00121359	0.12088308209695348
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00121359	0.12088308209695348
SECKEL SYNDROME 8; SCKL8	0.00121359	0.12088308209695348
